Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis

Dermatologic Surgery

Volumn 34, Issue 6, 2008, Pages 751-755

  Absar, Mohammed S ^a   Onwudike, Madu ^a  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; AXILLA; CAPILLARY RESISTANCE; COLORIMETRY; DRUG EFFICACY; FEMALE; GRAVIMETRY; HUMAN; HYPERHIDROSIS; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT SATISFACTION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF EVALUATION; SIDE EFFECT; STANDARD; STATISTICAL ANALYSIS; SYMPTOM; URTICARIA; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AXILLA; BOTULINUM TOXIN TYPE A; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERHIDROSIS; INJECTIONS, INTRADERMAL; MALE; NEUROMUSCULAR AGENTS; RECURRENCE; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); TREATMENT OUTCOME;

EID: 44849128403     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34142.x     Document Type: Article

References (21)

1. Stolman LP. Treatment of hyperhidrosis. J Drugs Dermatol 2003 2:521 7.
2. Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast Reconstr Surg 2002 110:222 8.
3. Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 2000 30:211 8.
4. Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol 1998 38:1 17.
5. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin 1998 16:863 9.
6. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004 Aug 51:241 8.
7. Scholes KT, Crow KD, Ellis JP, et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J 1978 2:84 5.
8. Holzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol 1984 110:399 403.
9. Moran KT, Brady MP. Surgical management of hyperhidrosis. Br J Surg 1991 78:279 83.
10. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatr 2004 75:951 7.
11. Breidenbach MA, Brunger AT. New insights into clostridial neurotoxin-SNARE interactions. Trends Mol Med 2005 11:377 81.
12. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: a review, part 1. Am J Health Syst Pharm 2006 63:145 52.
13. Naumann M, Lowe NJ, Kumar CR, et al. Botulinum toxin Type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 2003 139:731 6.
14. Naumann M, Lowe NJ. Botulinum toxin Type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, and placebo-controlled trial. BMJ 2001 323:596 9.
15. Whelchel DD, Brehmer TM, Brooks PM, et al. Molecular targets of botulinum toxin at the mammalian neuromuscular junction. Mov Disord 2004 19 (Suppl 8):S7 S16.
16. Lowe PL, Cerdan-Sanz S, Lowe NJ. Botulinum toxin Type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol Surg 2003 29:545 8.
17. Galadari I, Alkaabi J. Botulinum toxin in the treatment of axillary hyperhidrosis. Skinmed 2003 2:209 11.
18. Salmanpoor R, Rahmanian MJ. Treatment of axillary hyperhidrosis with botulinum-A toxin. Int J Dermatol 2002 41:428 30.
19. Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001 344:488 93.
20. Hornberger J, Grimes K, Naumann M, et al. Multi-specialty working group on the recognition, diagnosis, and treatment of primary focal hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004 51:274 86.
21. Nyamekye IK. Current therapeutic options for treating primary hyperhidrosis. Eur J Vas Surg 2004 27:571 6.